Perfluorocarbons as Blood Substitutes: The Early Years: Experience with Fluosol DA-20% in the 1980s

Clinical testing of perfluorocarbons (PFC) as blood substitutes began in the early 1980's in the form of Fluosol DA-20% (FDA), a mixture of perfluorodecalin and perfluorotripropylamine emulsified with Pluronic F68. We have treated 55 patients (Treatment (T) = 40; Control (C) = 15) with intraven...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Artificial cells, blood substitutes, and immobilization biotechnology blood substitutes, and immobilization biotechnology, 1994, Vol.22 (4), p.955-963
Hauptverfasser:	Spence, R. K., Norcross, E. D., Costabile, Joseph, McCoy, Sue, Cernaianu, Aurel C, Alexander, James B, Pello, Mark J, Atabek, Umur, Camishion, Rudolph C
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia - therapy Blood Substitutes - therapeutic use Clinical Trials as Topic Drug Combinations Fluorocarbons - therapeutic use Humans Hydroxyethyl Starch Derivatives Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!